BAYER 25 mg Pill - white capsule/oblong, 18mm
Generic Name: larotrectinib
Pill with imprint BAYER 25 mg is White, Capsule/Oblong and has been identified as Vitrakvi 25 mg. It is supplied by Bayer HealthCare Pharmaceuticals Inc.
Vitrakvi is used in the treatment of Solid Tumors and belongs to the drug class multikinase inhibitors. Vitrakvi 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BAYER 25 mg
Vitrakvi
- Generic Name
- larotrectinib
- Imprint
- BAYER 25 mg
- Strength
- 25 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bayer HealthCare Pharmaceuticals Inc.
- National Drug Code (NDC)
- 50419-0390
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Fam-trastuzumab deruxtecan
Trastuzumab deruxtecan (Enhertu, T-DXd) is a treatment for breast cancer, advanced stomach cancer ...
Selpercatinib
Selpercatinib is used for non small cell lung cancer, solid tumors, thyroid cancer
Dabrafenib
Dabrafenib is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer, solid ...
Trametinib
Trametinib is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer, solid ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
More about Vitrakvi (larotrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.